InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Insomnia, Brexit and the UPC: a fictional scenario


In our latest article looking at a UPC scenario, Nicola Dagg, Marc Döring, Alex Woolgar, David Por, Philipp Cepl and Laura Thompson consider a case that raises questions about jurisdiction, discovery and Brexit

In this fictional scenario our client is US-based innovative pharmaceutical company, Jones Pharma Inc. Jones manufactures and markets worldwide a medical device for the treatment of insomnia and related sleep disorders, branded SeroNight. SeroNight is a transdermal patch containing a...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Latest Country Updates

Supplements

Most read articles